Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
ACE2 Receptor Usage across Animal Species by SARS-CoV-2 Variants
Masato Hatta
1, Gloria P. Larson
1, Yasuko Hatta
1, Wei Wang, Nannan Jiang, Yu-Jin Jung, Li Wang, Xiaoyu Fan, Brenda M. Calderon, Gaston Bonenfant, Xudong Lin, Chenchen Feng, Dan Cui, Ginger Atteberry, Michael Currier, John Steel, David E. Wentworth, and Bin Zhou
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Hatta, Y. Hatta, N. Jiang, L. Wang, X. Fan, B.M. Calderon, X. Lin, D. Cui, G. Atteberry, M. Currier, J. Steel, D.E. Wentworth, B. Zhou); Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA (G.P. Larson, G. Bonenfant, C. Feng); General Dynamics Information Technology, Inc., Falls Church, Virginia, USA (W. Wang, Y.-J. Jung)
Main Article
Figure 1

Figure 1. Sequence comparison of ACE2 proteins among 54 animal species with phylogenetic tree of ACE2 proteins in study of ACE2 receptor usage across animal species by SARS-CoV-2 variants. Protein sequence of ACE2 from various species are aligned at residues in the SARS-CoV-2 spike protein binding interface. Percent identity to human ACE2 was calculated by pairwise alignment of individual ACE2s to human ACE2. Residues differing from human ACE2 residues are highlighted in yellow. Scale bar indicates the number of amino acid substitutions based on ACE2 protein sequences. ACE2, angiotensin-converting enzyme 2.
Main Article
Page created: June 16, 2025
Page updated: July 17, 2025
Page reviewed: July 17, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.